DUBLIN, Dec. 17, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/x428rl/global) has announced the addition of the "Global Hyperphosphatemia Drugs Market 2015-2019" report to their offering.
The report forecasts the global hyperphosphatemia drugs market to grow at a CAGR of 10.71% over the period 2014-2019.
In this report, the author the present scenario and growth prospects of the global hyperphosphatemia drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of branded, generic, OTC, and off-label drugs used for treating hyperphosphatemia.
Market drivers:
Market challenges:
Market trends:
Questions Answered:
Companies Mentioned Include:
Report Structure:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Product profiles
PART 05: Introduction
PART 06: Disease Overview
PART 07: Key developments in hyperphosphatemia therapy
PART 08: Guidelines for use of phosphate binders
PART 09: Pipeline analysis
PART 10: Market landscape
PART 11: Hyperphosphatemia management market dynamics
PART 12: Market segmentation by dosage form
PART 13: Market segmentation by formulation
PART 14: Geographical segmentation
PART 15: Key leading countries
PART 16: Market drivers
PART 17: Impact of drivers
PART 18: Market challenges
PART 19: Impact of drivers and challenges
PART 20: Market trends
PART 21: Vendor landscape
PART 22: Key vendor analysis
PART 23: Appendix
For more information visit http://www.researchandmarkets.com/research/x428rl/global
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article